MedPath

Optimizing Sleep Health in Nurses

Not Applicable
Recruiting
Conditions
Sleep Initiation and Maintenance Disorders
Circadian Rhythm Sleep-Wake Disorders, Shift Work Type
Interventions
Behavioral: CBTI
Behavioral: MRTI
Registration Number
NCT05965609
Lead Sponsor
Oregon State University
Brief Summary

The aim of the proposed study is to pilot test two behavioral sleep intervention strategies for improving insomnia among night shift working nurses.

Detailed Description

Night shift nurses with insomnia who meet all study criteria will receive one of two insomnia therapies. The specific therapy for insomnia will be determine by chance (like a flip of a coin), with an equal chance to receive either cognitive-behavioral therapy for insomnia or multicomponent relaxation therapy for insomnia, both modified for shift workers. Both therapies will be conducted over telehealth by interventionists trained in behavioral sleep medicine.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Current shift working nursing staff in Oregon
  • Expect to continue on shift work schedule during the study
  • Meets criteria for an insomnia disorder
  • Elevated insomnia symptoms
  • Have daily access to internet on a smartphone, tablet, or computer; and
  • Can read and write in English
Exclusion Criteria
  • People with uncontrolled medical conditions
  • Presence of safety risk or condition in which study participation may be ineffective or result in increased risk to safety
  • Some current treatments for insomnia
  • Permanent day, evening, or rotating shift schedule
  • History of seizures or manic episode; or
  • Current/expected pregnancy during the study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CBTICBTICognitive Behavioral Therapy for Insomnia
MRTIMRTIMulticomponent Relaxation Therapy for Insomnia
Primary Outcome Measures
NameTimeMethod
Change in Insomnia Severity IndexAt baseline and at the post-treatment assessment (occurring at approximately 10 weeks)

Validated questionnaire; total score range between 0 and 28, with higher numbers representing greater insomnia severity

Retention RateAt the post-treatment assessment (occurring at approximately 10 weeks)

Defined as \[number of participants who complete minimal therapeutic dose (at least 4 sessions)\] / \[number of randomized participants in treatment arm\]

Session AttendanceAt the post-treatment assessment (occurring at approximately 10 weeks)

For enrolled participants, attendance rates will be calculated as \[number of visits attended\] / \[number of total visits\]

Implementation Assessment MeasureAt the post-treatment assessment (occurring at approximately 10 weeks)

Validated questionnaire; total score range between 12 and 60, with higher numbers representing greater feasibility, acceptability, and appropriateness.

Secondary Outcome Measures
NameTimeMethod
Change in PROMIS Sleep Related Impairment 8 itemAt baseline and at the post-treatment assessment (occurring at approximately 10 weeks)

Validated questionnaire; total score range between 8-40, with higher numbers indicating greater sleep-related wake time impairment

Change in Fatigue Severity ScaleAt baseline and at the post-treatment assessment (occurring at approximately 10 weeks)

Validated questionnaire; total score range between 9 and 63, with higher numbers representing greater fatigue.

Trial Locations

Locations (1)

Oregon State University

🇺🇸

Corvallis, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath